XML 157 R2.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Comprehensive Loss - USD ($)
 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2022
Continuing operations      
Revenue $ 5,625,124 $ 905,049
Cost of sales (5,152,543) (1,048,354)
Other income 495,468
Research and development expense (1,772,273) (1,351,217) (985,158)
Marketing expense (643,060) (256,421) (105,060)
Administrative expense (7,522,850) (4,808,655) (2,523,230)
Other operating expense (72,717) (94,207) (38,985)
Loss from operations (9,042,851) (6,653,805) (3,652,433)
Financial costs (1,165,418) (160,035) (2,130)
Other financial results 1,868,964 1,030,525 (872,342)
Transaction expenses (3,535,046)
Share based payment cost of listing shares (42,705,061)
Gain/(loss) investment in associates (19,940)
Net loss before Income tax (8,359,245) (52,023,422) (4,526,905)
Income tax benefit 1,046,985 234,542
Net loss for the year $ (7,312,260) $ (51,788,880) $ (4,526,905)
Basic loss per share (in Dollars per share) $ (0.19) $ (1.5) $ (0.15)
Diluted loss per share (in Dollars per share) $ (0.19) $ (1.5) $ (0.15)
Items that may be reclassified to profit or loss:      
Foreign exchange differences on translation of foreign operations $ 107,597 $ 18,112
Total other comprehensive income 107,597 18,112
Total comprehensive loss for the year $ (7,204,663) $ (51,770,768) $ (4,526,905)